Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

LA Jolla Pharma (LJPC)

LA Jolla Pharma (LJPC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 99,170
  • Shares Outstanding, K 27,471
  • Annual Sales, $ 33,420 K
  • Annual Income, $ -39,420 K
  • 60-Month Beta 2.36
  • Price/Sales 2.96
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LJPC with:

Options Overview

Details
  • Implied Volatility 133.36%
  • Historical Volatility 49.54%
  • IV Percentile 83%
  • IV Rank 58.39%
  • IV High 189.28% on 09/11/20
  • IV Low 54.88% on 05/21/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 306
  • Volume Avg (30-Day) 95
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 2,809
  • Open Int (30-Day) 2,896

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.57
  • Growth Rate Est. (year over year) +77.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.55 +1.69%
on 07/29/21
4.30 -16.05%
on 07/06/21
-0.70 (-16.24%)
since 07/02/21
3-Month
3.35 +7.76%
on 05/13/21
5.69 -36.56%
on 06/03/21
-0.83 (-18.69%)
since 04/30/21
52-Week
3.35 +7.76%
on 05/13/21
7.85 -54.01%
on 02/10/21
-0.37 (-9.30%)
since 07/31/20

Most Recent Stories

More News
Thinking about buying stock in La Jolla Pharmaceutical, The GEO Group, Abeona Therapeutics, Sellas Life Sciences, or Naked Brand?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LJPC, GEO, ABEO, SLS, and NAKD.

SLS : 9.11 (+6.43%)
ABEO : 1.2900 (+5.74%)
LJPC : 3.61 (unch)
NAKD : 0.5500 (+3.97%)
GEO : 6.90 (-0.29%)
Moving Average Crossover Alert: La Jolla Pharmaceutical (LJPC)

La Jolla Pharmaceutical (LJPC) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

LJPC : 3.61 (unch)
La Jolla Pharmaceutical (LJPC) Misses Q1 Earnings Estimates

La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of -37.31% and 2.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?...

LJPC : 3.61 (unch)
La Jolla Pharmaceutical: Q1 Earnings Snapshot

SAN DIEGO (AP) _ La Jolla Pharmaceutical Co. (LJPC) on Friday reported first-quarter net income of $14.4 million, after reporting a loss in the same period a year earlier.

LJPC : 3.61 (unch)
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.61 (unch)
La Jolla Pharmaceutical (LJPC) Reports Q4 Loss, Tops Revenue Estimates

La Jolla Pharmaceutical (LJPC) delivered earnings and revenue surprises of 62.86% and 7.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?...

LJPC : 3.61 (unch)
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Corporate Progress

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...

LJPC : 3.61 (unch)
La Jolla Pharmaceutical (LJPC) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

La Jolla Pharmaceutical (LJPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LJPC : 3.61 (unch)
Uptrend Call Working As La Jolla Pharm Stock Rises 44.4% (LJPC)

SmarTrend identified an Uptrend for La Jolla Pharm (NASDAQ:LJPC) on September 16th, 2020 at $4.75. In approximately 5 months, La Jolla Pharm has returned 44.42% as of today's recent price of $6.86.

LJPC : 3.61 (unch)
La Jolla Pharm Up 59.4% Since SmarTrend Uptrend Call (LJPC)

SmarTrend identified an Uptrend for La Jolla Pharm (NASDAQ:LJPC) on September 16th, 2020 at $4.75. In approximately 5 months, La Jolla Pharm has returned 59.37% as of today's recent price of $7.57.

LJPC : 3.61 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases.

See More

Key Turning Points

3rd Resistance Point 3.73
2nd Resistance Point 3.68
1st Resistance Point 3.65
Last Price 3.61
1st Support Level 3.57
2nd Support Level 3.52
3rd Support Level 3.49

See More

52-Week High 7.85
Fibonacci 61.8% 6.13
Fibonacci 50% 5.60
Fibonacci 38.2% 5.07
Last Price 3.61
52-Week Low 3.35

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar